Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05699096
Other study ID # ROPFO
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2023
Est. completion date July 1, 2026

Study information

Verified date January 2023
Source EL Romany Ophthalmics Factory
Contact El R Ophthalmics
Phone +201212331343
Email drmina@elromanyophthalmics.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date July 1, 2026
Est. primary completion date July 1, 2025
Accepts healthy volunteers No
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - - Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing; Exclusion Criteria: - Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Egypt Girgis Boules Cairo Kubri EL Kubba

Sponsors (1)

Lead Sponsor Collaborator
EL Romany Ophthalmics Factory

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary flat the detached retina and displace the underneath fluids anteriorly the effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina Base line
See also
  Status Clinical Trial Phase
Recruiting NCT04956237 - Retinal Surgery With or Without Anesthesiologist, Comparison of Surgeon and Patient's Comfort
Recruiting NCT01432847 - Cell Collection to Study Eye Diseases
Active, not recruiting NCT04130841 - Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Active, not recruiting NCT03872479 - Single Ascending Dose Study in Participants With LCA10 Phase 1/Phase 2
Active, not recruiting NCT04636307 - Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)
Not yet recruiting NCT06451068 - Peripheral Retina Robotically Aligned OCT Study N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Completed NCT02315170 - Assessment of Novel Intraocular Injection Guide N/A
Completed NCT00069199 - Optical Coherence Tomography Comparative Study N/A
Withdrawn NCT03603990 - Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema N/A
Active, not recruiting NCT04123626 - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene Phase 1/Phase 2
Withdrawn NCT02445001 - Erythrocyte Ghost Mediated Retinal Diagnosis N/A
Completed NCT01468337 - Topical Interferon Gamma-1b for Central Serous Chorioretinopathy Phase 1/Phase 2
Completed NCT01227993 - Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Phase 1/Phase 2
Completed NCT00792259 - Topcon 3D OCT-1000 Optical Coherence Tomography System
Completed NCT00035906 - Research Study in Patients With Persistent Macular Edema Phase 2
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Terminated NCT04110015 - Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis
Recruiting NCT03592017 - Performance of Long-wavelength Autofluorescence Imaging N/A